Efficacy and Safety of Tofacitinib in Pediatric Patients with Alopecia Areata: A Prospective Cohort Study
January 2025
in “
International Journal of Dermatology Venereology and Leprosy Sciences
”
Studysummary This study found that oral tofacitinib significantly reduced alopecia severity and improved quality of life over 12 months for children with moderate to severe alopecia areata, though the authors recommend more research due to the small sample size and absence of a control group.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on dermatologypaper.com →